REGN wins FDA nod to extend Eylea HD dosing to 20 weeks, boosting flexibility for wAMD and DME patients while reinforcing its push to offset declining Eylea sales.

Description: Discord: ...

Description: Discord: ...

The Food and Drug Administration (FDA) has approved extended dosing intervals for Eylea HD ® (aflibercept) for patients with wet age-related macular degeneration (wAMD) and diabetic macular edema (DME ...

Regeneron Pharmaceuticals has won Food and Drug Administration approval of extended dosing intervals of up to every 20 weeks for its Eylea HD eye drug.

Dr. Sharon Cobb, the Associate Program Manager for NASA's SLS program joins FOX 35's Garrett Wymer live via Zoom to preview ...

Over 30 years after graduating from Carnegie Mellon University, The Home Depot Chief Executive Officer, chairman, and president Edward “Ted” Decker returned on Thursday to his alma mater to ...

The US Central Command (CENTCOM) said that around 3,500 US marines and sailors have arrived in the Middle East as part of a West Asia War ...

South Korea's DAPA officially announced the bid for the KDDX next-generation destroyer program on March 23 and distributed ...

Did you buy QURE ordinary shares between September 24, 2025, and October 31, 2025? Affected uniQure N.V. Investor SummaryWho: ...

The FDA approved Wegovy HD, a higher-dose semaglutide for weight loss in adults with obesity, offering greater weight ...

The U.S. Food and Drug Administration has approved a new dose of the GLP-1 class weight loss drug Wegovy that’s three times ...